[Pharmacogenetics and age-related macular degeneration, towards an individualized treatment of the disease].
Servicio de Oftalmología, Hospital Universitario de Salamanca, Salamanca, España; Instituto de Investigación Biomédica de Salamanca, Hospital Universitario de Salamanca, Salamanca, España. Electronic address: cruzgonzalez.fernando@gmail.com.
F
F
Cruz-González
L
L
Cabrillo Estévez
G
G
López-Valverde
F
F
Escudero-Domínguez
R
R
González-Sarmiento
D020533:Angiogenesis Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003179:Complement C3b / Q000235:genetics; D017242:Complement Factor H / Q000235:genetics*; D004200:Diseases in Twins; D004351:Drug Resistance / Q000235:genetics; D056726:Genetic Association Studies; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D000074289:High-Temperature Requirement A Serine Peptidase 1; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine; D011506:Proteins / Q000235:genetics; D012697:Serine Endopeptidases / Q000235:genetics; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
C514392:ARMS2 protein, human; D020533:Angiogenesis Inhibitors; D011506:Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D003179:Complement C3b; D017242:Complement Factor H; D000074289:High-Temperature Requirement A Serine Peptidase 1; C474012:HTRA1 protein, human; D012697:Serine Endopeptidases